Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination nasal spray of fluticasone and azelastine for allergic rhinitis
IRCT20250927067374N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of azelastine + fluticasone in allergic rhinitis (AR), sponsored by Tabriz University of Medical Sciences. Started Oct 2025; status: completed.
02
Drugs
azelastine + fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20250927067374N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250927067374N1.